
Analgesics in Italy
Description
Analgesics in Italy
Analgesics is set to see a decline in retail value sales in current terms in Italy in 2024. The category’s performance was adversely affected by a peculiar flu season. Despite the record 14.5 million infections reported by RespiVirNet, the flu season showed an unusual pattern. In fact, the high number of infections was contrasted by a rather narrow time frame, with the peak concentrated at the end of December 2023. This led to a drop in analgesics sales as early as the second week of January. Th...
Euromonitor International's Analgesics in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
26 Pages
- Analgesics in Italy
- Euromonitor International
- September 2024
- List Of Contents And Tables
- ANALGESICS IN ITALY
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Unexpectedly short flu season stalls analgesics sales
- Ibuprofen's broad appeal fuels growth despite unusual flu season driven by quick release formulations
- Topical analgesics/anaesthetic continues to suffer from the poor performance of patches and competition from non-medicated options.
- PROSPECTS AND OPPORTUNITIES
- Chronic pain treatment as an opportunity for analgesics despite competition from non-pharmacological alternatives
- Women’s health focus to drive growth for specifically targeted analgesics
- Topical analgesics/anaesthetic category to shift to more comfortable formats and better user experience
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2019-2024
- Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
- CONSUMER HEALTH IN ITALY
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.